|
ANGEL1 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 7.756400E-02 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.279800E-01 |
| Normal-vs-Stage2 |
6.543200E-01 |
| Normal-vs-Stage3 |
4.475500E-02 |
| Normal-vs-Stage4 |
2.002000E-02 |
| Stage1-vs-Stage2 |
4.244000E-01 |
| Stage1-vs-Stage3 |
3.620400E-01 |
| Stage1-vs-Stage4 |
2.375600E-01 |
| Stage2-vs-Stage3 |
2.100000E-01 |
| Stage2-vs-Stage4 |
1.467040E-01 |
| Stage3-vs-Stage4 |
6.667200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.709610E-01 |
| Normal-vs-AfricanAmerican |
7.071700E-02 |
| Normal-vs-Asian |
1.406620E-01 |
| Caucasian-vs-AfricanAmerican |
3.899000E-01 |
| Caucasian-vs-Asian |
7.189600E-01 |
| AfricanAmerican-vs-Asian |
5.520600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
4.450000E-02 |
| Normal-vs-Female |
1.166960E-01 |
| Male-vs-Female |
4.171800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.592600E-01 |
| Normal-vs-Age(41-60Yrs) |
1.187800E-01 |
| Normal-vs-Age(61-80Yrs) |
9.664400E-02 |
| Normal-vs-Age(81-100Yrs) |
1.421800E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.428000E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
6.265400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.500400E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.439600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.511400E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.845000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.58160000000218E-05 |
| Classical-VS-Follicular |
5.243600E-02 |
| Classical-VS-Other |
1.307250E-01 |
| Classical-VS-Normal |
3.868000E-01 |
| Tall-VS-Follicular |
6.288400E-02 |
| Tall-VS-Other |
8.786000E-01 |
| Tall-VS-Normal |
8.34110000000887E-05 |
| Follicular-VS-Other |
5.182800E-01 |
| Follicular-VS-Normal |
3.982500E-02 |
| Other-VS-Normal |
5.990000E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.310780E-01 |
| Normal-vs-N1 |
1.869540E-02 |
| N0-vs-N1 |
2.089000E-01 |
|
|
